Methods:Two hundred MSM aged 16 to 20 were recruited via community and other sources. Men were tested for HPV DNA from the anal canal and penis, and completed a questionnaire.
Findings: Median age was 19. Men reported a median duration of 1·9 years since first receptive anal sex and a median of 4 receptive anal sex partners. The proportion of men with anal HPV of any type increased from 10·0% in men reporting no prior receptive anal sex to 47·3% in men reporting ≥4 receptive anal sex partners (p-trend<0·001). The proportion with anal HPV type 16 also increased significantly with increasing receptive anal sex partners (p trend=0·044). The proportion of men with penile HPV increased from 3·7% in men reporting no prior insertive anal sex to 14·8% in men reporting ≥4 insertive anal sex partners (p-trend=0·014). Overall, 39·0% (95% confidence interval (CI): 32·2-46·1%) of men had at least one HPV DNA type detected: 23·0% (95% CI: 17·4-29·5%) with a quadrivalent HPV vaccine preventable type (6, 11, 16 or 18).
Conclusion: These data suggest early and high per partner transmission of HPV among MSM soon after their first sexual experiences. HPV vaccination needs to commence early for maximal prevention of HPV among MSM.
The case is of a 30 year-old HIV positive Zimbabwean woman (UK resident) who arrived in Australia in January 2011 on a one-year working visa. She was diagnosed with HIV in 2003 in the UK and commenced on Atripla® in 2005. She was first seen in Adelaide in May 2011, requesting a script for Atripla.®.
Background: Liquid based anal Papanicolaou smears, followed by High Resolution Anoscopy (HRA) guided biopsies are increasingly being advocated to identify areas of High Grade Anal Intraepithelial Neoplasia (HGAIN). We hypothesized that the ability to identify HGAIN would increase with experience of the anoscopist, and that comparison with contemporary Papanicolaou smears might yield insights into technical abilities.
Indigenous Australians experience a greater burden of sexually transmitted infections, however are less likely than the general population to access sexual health services. We examined the effectiveness of an Indigenous cultural appropriateness audit in assessing a sexual health clinic with low rates of Indigenous clients.
Despite the high proportion of young people annually accessing general practices, including Aboriginal Medical Services (AMS), testing for Chlamydia trachomatis remains relatively low in urban areas. A project officer was employed within the Institute of Urban Indigenous Health (IUIH) to serve a mentoring and facilitation role for the SE Queensland network of AMS and their sexual health workers, with a view to improving testing, management and follow-up of chlamydia and other STIs by community controlled medical services.
Monocytes are a heterogeneous cell population having specialised functions and differing phenotype. They are a link between innate immune system and adaptive immune system therefore, to identify if immune activation exists in HIV-1 individuals with controlled virema and recovered CD4 T cell counts, we assessed cell surface monocyte activation markers (MAM) within the monocyte subsets.
Involving consumers in healthcare decisions is important for high quality care. We previously tested a brief, consumer-led intervention consisting of three questions in a trial employing trained, standardized patients. The intervention enhanced discussion of evidence and increased patient involvement. We now report a research translation study which tested implementation with real patients at a reproductive and sexual health clinic.
This presentation, "Responding to the needs of consumers with complex trauma histories a consumer perspective" focuses on the needs of adult survivors of child abuse, highlighting the frequent